文献速递临床试验与 GCP流行病学与生物统计真实世界研究与卫生经济

老年癌症患者及其家庭照护者导航项目的实施与评估:EU NAVIGATE 国际实用性随机对照试验研究方案

Implementation and evaluation of a navigation program for people with cancer in old age and their family caregivers: study protocol for the EU NAVIGATE International Pragmatic Randomized Controlled Trial.
PubMed 文献 · Trials · 2024-11-27

EU NAVIGATE 是在比利时、爱尔兰、意大利、荷兰、波兰和葡萄牙开展的多中心实用性快速通道随机对照试验,比较 NavCare-EU 干预联合标准照护与单纯标准照护。研究对象为 70 岁及以上、健康状况下降的癌症患者及其近亲家庭照护者,主要结局为 24 周时 EORTC-QLQ-C30(修订版)整体健康状况/生活质量 2 条目子量表和 MOS-SSS 社会支持水平。

要点

  • 纳入 70 岁及以上健康状况下降的癌症患者及其近亲家庭照护者。
  • 比较 NavCare-EU 干预联合标准照护与单纯标准照护。
  • 24 周主要结局为整体健康状况/生活质量与社会支持水平。

核心结论

  • EU NAVIGATE 试验将在不同国家间检验针对老年癌症患者及其家庭照护者的导航干预的有效性、成本效果及其在欧洲不同医疗体系中的实施情况。

研究设计与样本

  • 在比利时、爱尔兰、意大利、荷兰、波兰和葡萄牙开展多中心实用性快速通道随机对照试验,并嵌入收敛式混合方法过程评估。
  • 研究对象为 70 岁及以上、健康状况下降的癌症患者及其近亲家庭照护者。
  • 随机分组前进行基线测量,干预组和对照组在 12 周、24 周和 48 周进行随访测量,对照组另在 72 周进行一次测量。
  • 研究将纳入至少 246 名在 24 周时完成整体健康状况/生活质量评估的老年人。

关键数值与推荐

  • 主要结局在 24 周测量,包括 EORTC-QLQ-C30(修订版)中测量健康相关生活质量的整体健康状况/生活质量 2 条目子量表。
  • 另一主要结局为采用医学结局研究社会支持调查(MOS-SSS 量表)测量的社会支持水平。
  • 研究将纳入至少 246 名在 24 周时完成整体健康状况/生活质量评估的老年人。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cancer navigation programs aim to support, educate, and empower patients and families, addressing barriers to diagnostics, treatment, and care. Navigators engage with people to ensure timely access to services and resources. While promising for older people with cancer, these programs are scarce in Europe, and research on their effectiveness and implementation is limited. We describe the protocol of the EU NAVIGATE randomized controlled trial, aimed to evaluate (1) effectiveness and cost-effectiveness of NavCare-EU, an intervention that aims to support older people with cancer throughout their illness trajectory, spanning the continuum of supportive, palliative, and end-of-life care, and (2) the intervention's implementation processes and feasibility of its integration into different health care systems in Europe, contextual barriers and facilitators for effective and sustainable implementation, and mechanisms involved in reaching the outcomes. METHODS: We will conduct a multisite pragmatic fast-track randomized controlled trial with embedded convergent mixed-method process evaluation in Belgium, Ireland, Italy, Netherlands, Poland, and Portugal. The study targets people with cancer and declining health, 70 years or older, and their close family caregivers. The trial compares the NavCare-EU intervention plus standard care with standard care alone. We will perform a baseline measurement prior to randomization and follow-up measurements at 12 weeks, 24 weeks, and 48 weeks in intervention and control group, and an additional measurement at 72 weeks in the control group. Primary outcomes, measured at 24 weeks are (1) the older person's global health status/quality of life, a 2-item subscale from EORTC-QLQ-C30 (revised) measuring health-related quality of life, (2) level of social support measured with Medical Outcomes Study Social Support Survey (MOS-SSS scale). The study will include at least 246 older persons with completed global health status/quality of life at 24 weeks. DISCUSSION: The EU NAVIGATE trial will cross-nationally test the effectiveness and cost-effectiveness of a navigation intervention for older people with cancer and their family caregivers, and its implementation in different health care systems in Europe. As continuity and access to health, social, and community care is a priority for patients and caregivers, the trial is timely and critically needed. TRIAL REGISTRATION: Clinicaltrials.gov: identifier NCT06110312 (2023/10/31).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Smets T, Pivodic L, Miranda R, et al. Implementation and evaluation of a navigation program for people with cancer in old age and their family caregivers: study protocol for the EU NAVIGATE International Pragmatic Randomized Controlled Trial. Trials. 2024. PMID: 39605055. doi:10.1186/s13063-024-08633-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。